CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-13 | SHAROKY MELVIN MD Director | Gift | −6,100 | 284,516 | ||
| 2025-08-13 | SHAROKY MELVIN MD Director | Gift | −15,000 | 900 | ||
| 2025-08-13 | SHAROKY MELVIN MD Director | Gift | +5,000 | 6,847 | ||
| 2025-08-12 | SHAROKY MELVIN MD Director | Sale | −10,000 | $121.58 | $1.2M | 290,616 |
| 2025-08-04 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +8,715 | $19.74 | $172K | 91,826 |
| 2025-08-04 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −8,715 | $109.50 | $954K | 83,111 |
| 2025-08-04 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −8,715 | 26,145 | ||
| 2025-08-04 | Lewis William Chair and CEO | Option exercise 10b5-1 | +6,830 | $10.85 | $74K | 240,754 |
| 2025-08-04 | Lewis William Chair and CEO | Sale 10b5-1 | −1,693 | $108.80 | $184K | 239,061 |
| 2025-08-04 | Lewis William Chair and CEO | Sale 10b5-1 | −3,199 | $109.68 | $351K | 235,862 |
| 2025-08-04 | Lewis William Chair and CEO | Sale 10b5-1 | −1,938 | $110.91 | $215K | 233,924 |
| 2025-08-04 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,830 | 6,865 | ||
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +3,443 | $26.46 | $91K | 87,460 |
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +11,455 | $28.88 | $331K | 98,915 |
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +15,890 | $29.13 | $463K | 114,805 |
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise 10b5-1 | +17,100 | $34.03 | $582K | 131,905 |
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −32,090 | $102.38 | $3.3M | 99,815 |
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Sale 10b5-1 | −26,310 | $103.03 | $2.7M | 73,505 |
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −3,443 | 8,580 | ||
| 2025-07-21 | Bonstein Sara Chief Financial Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −11,455 | 0 |
Page 19 of 23 · 448 trades